| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Podnos Yale | Chief Medical Officer | C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS | By: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Yale Podnos | 22 May 2025 | 0001891104 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Common stock | Disposed to Issuer | $4,818 | -1,801 | -0.76% | $2.68 | 234,336 | 21 May 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. |